Edmond DE Rothschild Holding S.A. Invests $29.86 Million in CVS Health Corporation $CVS

Edmond DE Rothschild Holding S.A. acquired a new stake in CVS Health Corporation (NYSE:CVS) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 288,689 shares of the pharmacy operator’s stock, valued at approximately $29,865,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CVS. BlackRock Inc. purchased a new stake in shares of CVS Health in the second quarter valued at approximately $12,747,462,000. Norges Bank purchased a new position in CVS Health in the fourth quarter worth $1,666,265,000. Wellington Management Group LLP lifted its holdings in CVS Health by 193.2% in the fourth quarter. Wellington Management Group LLP now owns 18,564,392 shares of the pharmacy operator’s stock valued at $1,473,270,000 after acquiring an additional 12,233,675 shares during the period. Pzena Investment Management LLC purchased a new stake in shares of CVS Health during the 2nd quarter worth $1,217,558,000. Finally, Bank of New York Mellon Corp acquired a new position in shares of CVS Health during the 2nd quarter worth $932,454,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of research analyst reports. Morgan Stanley increased their price target on shares of CVS Health from $106.00 to $111.00 and gave the company an “overweight” rating in a report on Thursday, June 4th. JPMorgan Chase & Co. upped their target price on shares of CVS Health from $111.00 to $118.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th. Barclays increased their target price on shares of CVS Health from $106.00 to $108.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Weiss Ratings raised CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, August 5th. Finally, Argus upped their price target on CVS Health from $104.00 to $114.00 and gave the stock a “buy” rating in a report on Wednesday. Twenty-two analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $107.17.

CVS Health Trading Down 1.4%

Shares of CVS opened at $93.58 on Thursday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. CVS Health Corporation has a 1-year low of $69.51 and a 1-year high of $110.68. The stock has a market cap of $119.68 billion, a price-to-earnings ratio of 24.76, a price-to-earnings-growth ratio of 0.91 and a beta of 0.61. The firm has a 50 day simple moving average of $102.32 and a 200-day simple moving average of $88.69.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. The firm had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.CVS Health’s revenue was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities analysts forecast that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were paid a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.8%. CVS Health’s dividend payout ratio (DPR) is presently 70.37%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.